LLY vs PGC · P/E 39, rev $65.18B vs P/E 18, rev $228.1M
Eli Lilly and Company (LLY) versus Peapack-Gladstone Financial (PGC) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Peapack-Gladstone Financial (PGC) is a banks - regional company listed on NASDAQ.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported PGC revenue for 2024-12-31 was $228.1M. Net income was $33.0M. Revenue was down 0.7% from 2023-12-31 to 2024-12-31. PGC currently screens at market cap $778.9M and trailing P/E 17.8.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. PGC currently screens at market cap $778.9M and trailing P/E 17.8.
Not investment advice. Open the LLY and PGC stock pages for the full models.
Not investment advice.